Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00585676 · ClinicalTrials.gov registry record
Impact of Antenatal Betamethasone on Plasma Glucose Levels
A clinical trial, sponsored by University of California, Irvine.
- Completed
- Registry status
- 45
- Enrollment target
NCT00585676 is a clinical trial that has completed, run by University of California, Irvine. The registered enrollment target is 45 participants.
The verdict
NCT00585676 has completed, sponsored by University of California, Irvine.
- COMPLETED
- Registry status
- 45 participants
- Enrollment target
Study Summary
It is known that administration of steroids increases blood sugar levels. Administration of betamethasone is common practice during pregnancy to women at risk for preterm delivery. However, it is unknown the magnitude of the changes in glucose these women have after receiving betamethasone. The purpose of this study is to determine the magnitude and timing of the increase in blood sugar in pregnant women without diabetes who receive steroids.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2007-11 |
| Est. Completion | 2011-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00585676
The ClinicalTrials.gov registry entry for NCT00585676 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Irvine, which has 368 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00585676 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00585676 about?
NCT00585676 is a clinical study titled "Impact of Antenatal Betamethasone on Plasma Glucose Levels". It is known that administration of steroids increases blood sugar levels. Administration of betamethasone is common practice during pregnancy to women at risk for preterm delivery. However, it is unknown the magnitude of the changes in glucose these women have after receiving betamethasone. The purp...
What is the current status of trial NCT00585676?
This trial is currently completed. The enrollment target is 45 participants. The study started on 2007-11. Estimated completion is 2011-05.
Who is sponsoring clinical trial NCT00585676?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.